Sumeet Mantri

Sr Director, Us Forecasting and Strategic Analytics, Rare Tumors @EMD Serono, Inc.

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2026 — Present

Sr Director, Us Forecasting and Strategic Analytics, Rare Tumors @EMD Serono, Inc.

View department →

Boston, MA, US

Leading the end‑to‑end internalization of the forecasting and strategic analytics function for the US Rare Tumor business, establishing an integrated capability that spans revenue and volume demand forecasting, performance reporting, and advanced analytics. Building and scaling the US forecasting infrastructure, developing robust processes, models, and operating rhythms to support strategic planning, commercial decision‑making, and long‑range business outlooks.

EDUCATION

2003 — 2007

Smriti College Of Pharmaceutical Education Indore (MP) India

B-Pharm, Pharmaceutics,Pharmacognosy and Pharmacology

1989 — 2003

Shri Matri Vidya Mandir,Aurobindo Aashram,Ratlam (MP) India

School

2009 — 2011

SIES College Of Management Studies,Mumbai, India

MBA, Pharmaceutical Management

SKILLS

Pharmaceutical SalesPharmaceuticsMarket AccessSales OperationsTeam ManagementCompetitive IntelligenceDiabetesCompetitive AnalysisManagementHealthcareAnalytical SkillsAnalysisAnalyticsForecastingPharmaceutical IndustryPharmaceuticalsProduct LaunchMarket ResearchSales EffectivenessMarket Analysis

ABOUT SUMEET MANTRI

Bringing 14 years of extensive experience in the US and global pharmaceutical industry, with a strong focus on analytics and forecasting. Successfully supported the end-to-end journey of a US product launch, navigating through unforeseen challenges such as the COVID-19 pandemic. Played a key role in shaping and executing commercial strategy, contributing to a successful market entry and sustained performance.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Sumeet Mantri — Sr Director, Us Forecasting and Strategic Analytics, Rare Tumors at EMD Serono, Inc. in Boston, MA, US | Unifers